Clinical trial
MK0431A Comparative Study in Patients With Type 2 Diabetes…
NCT00482729 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00482729 |
|---|---|
| Title | MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED) |
| Official title | A Randomized, Double-Blind, Active-Comparator Controlled, Clinical Trial to Study the Efficacy and Safety of MK0431A for the Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | sitagliptin phosphate (+) metformin hydrochloride, metformin |
| Enrollment | 1,246 |
| Start date | Jun 19, 2007 |
| Primary completion | Nov 3, 2008 |
| Completion | Apr 27, 2009 |
| First posted | Jun 5, 2007 |
| Last update posted | Jun 9, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: